{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:22:05Z","timestamp":1794324125980,"version":"4.9.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["2018-0297"],"award-info":[{"award-number":["2018-0297"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","gastrojournal.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1053\/j.gastro.2024.08.018","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T20:29:01Z","timestamp":1724444941000},"page":"1429-1445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Recompensation of Chronic Hepatitis C\u2013Related Decompensated Cirrhosis Following Direct-Acting Antiviral Therapy: Prospective Cohort Study From a Hepatitis C Virus Elimination Program"],"prefix":"10.1053","volume":"167","author":[{"given":"Madhumita","family":"Premkumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radha K.","family":"Dhiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Duseja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Mehtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Taneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekta","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anchal","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prerna","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahaj","family":"Rathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nipun","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand V.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish","family":"Bhujade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreedhara B.","family":"Chaluvashetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gagandeep S.","family":"Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasvinder","family":"Nain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Rajender","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2024.08.018_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200461","article-title":"The burden of hepatitis C virus infection in Punjab, India: a population-based serosurvey","volume":"13","author":"Sood","year":"2018","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2024.08.018_bib2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11938-019-00240-7","article-title":"Hepatitis C elimination: a Public Health Perspective","volume":"17","author":"Dhiman","year":"2019","journal-title":"Curr Treat Options Gastroenterol"},{"key":"10.1053\/j.gastro.2024.08.018_bib3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S2468-1253(22)00386-7","article-title":"Global reporting of progress towards elimination of hepatitis B and hepatitis C","volume":"8","author":"Cui","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2024.08.018_bib4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/cld.978","article-title":"Hepatitis C virus elimination by 2030: conquering Mount Improbable","volume":"16","author":"Dhiman","year":"2020","journal-title":"Clin Liver Dis"},{"key":"10.1053\/j.gastro.2024.08.018_bib5","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jhep.2019.07.006","article-title":"Decentralized care with generic direct-acting antivirals in the management of chronic hepatitis C in a public health care setting","volume":"71","author":"Dhiman","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.08.018_bib6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/MPG.0000000000002139","article-title":"Direct-acting antiviral therapy is safe and effective in pediatric chronic hepatitis C: the public health perspective","volume":"68","author":"Dhiman","year":"2019","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1053\/j.gastro.2024.08.018_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101148","article-title":"Outcomes of real-world integrated HCV microelimination for people who inject drugs: an expansion of the Punjab Model","volume":"41","author":"Dhiman","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1053\/j.gastro.2024.08.018_bib8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/liv.14685","article-title":"Sofosbuvir and velpatasvir combination is safe and effective in treating chronic hepatitis C in end-stage renal disease on maintenance haemodialysis","volume":"41","author":"Taneja","year":"2021","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2024.08.018_bib9","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jhep.2020.11.021","article-title":"Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity","volume":"74","author":"Krassenburg","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.08.018_bib10","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jhep.2020.03.031","article-title":"DAA therapy and long-term hepatic function in advanced\/decompensated cirrhosis: real-world experience from HCV-TARGET cohort","volume":"73","author":"Verna","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.08.018_bib11","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1053\/j.gastro.2018.11.053","article-title":"Validation of Baveno VI criteria for screening and surveillance of esophageal varices in patients with compensated cirrhosis and a sustained response to antiviral therapy","volume":"156","author":"Thabut","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2024.08.018_bib12","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.dld.2022.12.014","article-title":"The Baveno VII concept of cirrhosis recompensation","volume":"55","author":"Reiberger","year":"2023","journal-title":"Dig Liver Dis"},{"key":"10.1053\/j.gastro.2024.08.018_bib13","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1053\/j.gastro.2018.03.022","article-title":"Baseline factors associated with improvements in decompensated cirrhosis after direct-acting antiviral therapy for Hepatitis C virus infection","volume":"154","author":"El-Sherif","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2024.08.018_bib14","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.08.018_bib15","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/jmv.25552","article-title":"Efficacy of direct-acting antivirals: UK real-world data from a well-characterised predominantly cirrhotic HCV cohort","volume":"91","author":"Macken","year":"2019","journal-title":"J\u00a0Med Virol"},{"key":"10.1053\/j.gastro.2024.08.018_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12072-018-9914-6","article-title":"Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity-LINA cohort)","volume":"13","author":"Gentile","year":"2019","journal-title":"Hepatol Int"},{"key":"10.1053\/j.gastro.2024.08.018_bib17","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/jvh.13039","article-title":"Improved liver transplant waitlist mortality and lower risk of disease progression among chronic hepatitis C patients awaiting liver transplantation after the introduction of direct-acting antiviral therapies in the United States","volume":"26","author":"Young","year":"2019","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1053\/j.gastro.2024.08.018_bib18","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.08.018_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221769","article-title":"Real-world cost-effectiveness of pan-genotypic Sofosbuvir-Velpatasvir combination versus genotype dependent directly acting anti-viral drugs for treatment of hepatitis C patients in the universal coverage scheme of Punjab state in India","volume":"14","author":"Chugh","year":"2019","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2024.08.018_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-042280","article-title":"Cost-effectiveness and budget impact analysis of facility-based screening and treatment of hepatitis C in Punjab state of India","volume":"11","author":"Chugh","year":"2021","journal-title":"BMJ Open"},{"key":"10.1053\/j.gastro.2024.08.018_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12876-020-01249-4","article-title":"Hepatocellular carcinoma occurs frequently and early after treatment in HCV genotype 3 infected persons treated with DAA regimens","volume":"20","author":"Tayyab","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"10.1053\/j.gastro.2024.08.018_bib22","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2893.2011.01481.x","article-title":"Role of hepatitis C virus genotype 3 in liver fibrosis progression--a systematic review and meta-analysis","volume":"18","author":"Probst","year":"2011","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1053\/j.gastro.2024.08.018_bib23","first-page":"541","article-title":"Hepatitis C virus genotype 3: clinical features, current and emerging viral inhibitors, future challenges","volume":"31","author":"Shahnazarian","year":"2018","journal-title":"Ann Gastroenterol"},{"key":"10.1053\/j.gastro.2024.08.018_bib24","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/apt.12646","article-title":"Review article: HCV genotype 3 \u2013 the new treatment challenge","volume":"39","author":"Ampuero","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2024.08.018_bib25","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1007\/s10620-016-4261-8","article-title":"Diabetes is associated with clinical decompensation events in patients with cirrhosis","volume":"61","author":"Liu","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2024.08.018_bib26","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1136\/gutjnl-2016-311609","article-title":"Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study","volume":"66","author":"Welzel","year":"2017","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2024.08.018_bib27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jceh.2022.08.002","article-title":"Recompensation in cirrhosis: current evidence and future directions","volume":"13","author":"Sharma","year":"2023","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1053\/j.gastro.2024.08.018_bib28","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jhep.2022.07.037","article-title":"Validation of Baveno VII criteria for recompensation in entecavir-treated patients with hepatitis B-related decompensated cirrhosis","volume":"77","author":"Wang","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.08.018_bib29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/apt.16658","article-title":"Determinants of re-compensation in patients with hepatitis B virus-related decompensated cirrhosis starting antiviral therapy","volume":"55","author":"Kim","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2024.08.018_bib30","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/apt.15586","article-title":"Hepatitis C eradication with direct-acting anti-virals reduces the risk of variceal bleeding","volume":"51","author":"Moon","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2024.08.018_bib31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/apt.15320","article-title":"Uptake of endoscopic screening for gastroesophageal varices and factors associated with variceal bleeding in patients with chronic hepatitis C infection and compensated cirrhosis, 2005-2016: a national database linkage study","volume":"50","author":"McDonald","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2024.08.018_bib32","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s12072-020-10105-2","article-title":"HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort","volume":"14","author":"Tanaka","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1053\/j.gastro.2024.08.018_bib33","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1053\/j.gastro.2017.06.012","article-title":"Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents","volume":"153","author":"Kanwal","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2024.08.018_bib34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jhep.2017.08.030","article-title":"HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma","volume":"68","author":"Ioannou","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2024.08.018_bib35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/hep.32341","article-title":"HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: a meta-analysis","volume":"76","author":"Lockart","year":"2022","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2024.08.018_bib36","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jceh.2021.06.023","article-title":"Use of sofosbuvir\/velpatasvir\/voxilaprevir for sofosbuvir nonresponder genotype 3 HCV infection in India","volume":"12","author":"Tiwari","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508524053599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508524053599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T09:47:31Z","timestamp":1732009651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508524053599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0016508524053599"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2024.08.018","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recompensation of Chronic Hepatitis C\u2013Related Decompensated Cirrhosis Following Direct-Acting Antiviral Therapy: Prospective Cohort Study From a Hepatitis C Virus Elimination Program","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2024.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the AGA Institute. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}